Avantax Advisory Services’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Hold |
9,104
| – | – | ﹤0.01% | 1655 |
|
|
2025
Q1 | $464K | Hold |
9,104
| – | – | ﹤0.01% | 1551 |
|
|
2024
Q4 | $411K | Hold |
9,104
| – | – | ﹤0.01% | 1573 |
|
|
2024
Q3 | $338K | Buy |
9,104
+16
| +0.2% | +$594 | ﹤0.01% | 1670 |
|
|
2024
Q2 | $278K | Buy |
9,088
+9
| +0.1% | +$275 | ﹤0.01% | 1744 |
|
|
2024
Q1 | $264K | Hold |
9,079
| – | – | ﹤0.01% | 1373 |
|
|
2023
Q4 | $250K | Hold |
9,079
| – | – | ﹤0.01% | 1339 |
|
|
2023
Q3 | $203K | Hold |
9,079
| – | – | ﹤0.01% | 1426 |
|
|
2023
Q2 | $369K | Buy |
+9,079
| New | +$369K | ﹤0.01% | 1079 |
|
|
2020
Q4 | – | Sell |
-9,379
| Closed | -$438K | – | 1254 |
|
|
2020
Q3 | $438K | Buy |
+9,379
| New | +$438K | 0.01% | 848 |
|